INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1997

Vitamin E supplementation, particularly at 200 mg/d, enhanced clinically relevant indexes of T-cell-mediated function in healthy elderly adults.

A randomized, double-blind, placebo-controlled study evaluated the effect of vitamin E supplementation (60, 200, or 800 mg/d vs. placebo) for 235 days in 88 healthy elderly subjects. Subjects consuming 200 mg/d showed a 65% increase in DTH and a 6-fold increase in antibody titer to hepatitis B compared to placebo (17% and 3-fold), 60-mg/d (41% and 3-fold), and 800-mg/d (49% and 2.5-fold) groups, as well as a significant increase in tetanus antibody titer. Vitamin E had no effect on diphtheria antibody titer, immunoglobulin levels, T- and B-cell counts, or autoantibody levels.

Study type
Randomized, double-blind, placebo-controlled trial
Who was studied
88 free-living, healthy subjects at least 65 years of age
What was measured
Delayed-type hypersensitivity skin response (DTH), vaccine antibody responses, and autoantibody levels

THE PAPER

Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.

Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, Thompson C, Pedrosa MC, Diamond RD, Stollar BD. JAMA, 1997.

PubMed 9134944 ↗DOI 10.1001/jama.1997.03540410058031 ↗

Nutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.